Pharming Group NV (PHAR) Social Stream



Pharming Group NV (PHAR): $9.31

0.26 (+2.87%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add PHAR to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#NR of 481

in industry

PHARMING GROUP NV (PHAR) Price Targets From Analysts

Use the tables below to see what analysts covering PHARMING GROUP NV think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-16 1 $43 $43 $43 $13 230.77%
2022-02-03 2 $43 $37 $40 $13 207.69%
2022-10-30 2 $37 $36 $36.5 $13 180.77%
2023-03-22 3 $37 $36 $36.5 $13 180.77%
2023-05-15 3 $40 $37 $38.5 $13 196.15%
2023-10-27 4 $40 $37 $38.5 $13 196.15%

The Trend in the Analyst Price Target


Over the past 169 days, PHAR's average price target has gone down $0.

PHAR reports an average of 218% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-16 3 37 36 36.5 12.000 204.17%
2023-03-28 3 40 37 38.5 12.700 203.15%
2023-05-11 3 40 37 38.5 10.210 277.08%
2023-05-15 4 40 37 38.5 11.611 231.58%
2023-05-15 3 40 37 38.5 11.611 231.58%

PHAR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 3 1 0 0 0 4

The Trend in the Broker Recommendations


PHAR's average broker recommendation rating worsened by 0.25 over the prior 52 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how PHARMING GROUP NV fares relative to all US stocks, note that its variance in analysts' estimates is lower than 69.77% of that group.
  • PHAR has a greater number of analysts covering the stock than 36.49% of all US stocks.
  • In the context of stocks in the small market cap category, PHARMING GROUP NV's average analyst price target is higher than 587.7% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, PHARMING GROUP NV's upside potential (average analyst target price relative to current price) is higher than 479.38% of them.

In the Pharmaceutical Products industry, GRCL, EFTR, and BOLT are the three stocks most similar to PHARMING GROUP NV regarding the price target and analyst recommendation information presented here.

What is the outlook for PHAR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!